| ACh | Acetylcholine |
| DMSO | Dimethyl sulfoxide |
| DNA | Deoxyribonucleic acid |
| EMA | European Medicines Agency |
| FDA | Food and Drug Administration |
| HeLa | Cervical adenocarcinoma |
| IC50 | Half maximal inhibitory concentration |
| ID50 | Compound concentration inhibiting by 50% the tumor-cell viability |
| IL-1β | Interleukin 1 beta |
| IL-6 | Interleukin 6 |
| MDA-MB-231 | Triple-negative breast cancer |
| miRNA-27 | Microrna |
| mRNA | Messenger RNA |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide |
| PBMC | Peripheral mononuclear blood cells |
| PBS | Phosphate-buffered saline |
| PT | Pentacyclic triterpenoids |
| ROS | Reactive oxygen species |
| SP | Specificity protein |
| SREBP | Sterol regulatory element-binding proteins |
| TNF-α | Tumor Necrosis Factor-α |
| TPP | Triphenylphosphonium |
| VEGFR | Vascular endothelial growth factor |